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MicroRNAs and p63 in epithelial stemness
E Candi1,2, I Amelio3, M Agostini3 and G Melino*,1,2,3
MicroRNAs (miRs) are a class of small noncoding RNAs that suppress the expression of protein-coding genes by repressing
protein translation. Although the roles that miRs and the miR processing machinery have in regulating epithelial stem cell
biology are not fully understood, their fundamental contributions to these processes have been demonstrated over the last few
years. The p53-family member p63 is an essential transcription factor for epidermal morphogenesis and homeostasis.
p63 functions as a determinant for keratinocyte cell fate and helps to regulate the balance between stemness, differentiation and
senescence. An important factor that regulates p63 function is the reciprocal interaction between p63 and miRs. Some miRs
control p63 expression, and p63 regulates the miR expression profile in the epidermis. p63 controls miR expression at different
levels. It directly regulates the transcription of several miRs and indirectly regulates their processing by regulating the
expression of the miR processing components Dicer and DGCR8. In this review, we will discuss the recent findings on the
miR–p63 interaction in epidermal biology, particularly focusing on the DNp63-dependent regulation of DGCR8 recently
described in the DNp63 / mouse. We provide a unified view of the current knowledge and discuss the apparent discrepancies
and perspective therapeutic opportunities.
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Facts
 Epidermal morphogenesis is governed by sets of micro-
RNAs(miRs) with different expression patterns.
 Epidermal-conditional deletion of miR processing machin-
ery components, such as DICER, Drosha and DGCR8, has
underscored the importance of miRs in epidermal morpho-
genesis and homeostasis.
 p63 is a master regulator of epidermal homeostasis; p63 /
and DNp63 / mice fail to develop a functional epidermis.
 p63 directly, via transcriptional regulation, and indirectly, by
promoting the transcription of Dicer and DGCR8, controls
the epidermal miR expression profile.
 The complex network between miRs and p63 regulates the
fate of epidermal cells.
Open Questions
 Where and when are epidermal/epithelial miRs precisely
expressed during epidermal/epithelial morphogenesis,
homeostasis and in different diseases?
 How do the isoforms DNp63 and TAp63 contribute to
epidermal homeostasis? And to what extent do miRs
contribute to the functioning of the p63 isoforms?
 Will the miR expression profiles provide innovative
biomarker tools in epidermal cancers?
 Will drugs targeting miR expression provide alternative
therapeutic approaches in epidermal oncology?
MicroRNAs (miRs) are a class of small noncoding RNA
(single-stranded RNAs consisting of 19–22 nucleotides) that
suppress the expression of protein-coding genes by repres-
sing protein translation by interacting with the 30UTR region of
messenger RNAs.1 The epidermal-conditional deletion of
components of the enzymatic complexes responsible for miR
maturation, such as DICER, Drosha and DGCR8, has
underscored the importance of miRs in the morphogenesis
and adult homeostasis of the epidermis.2–5
The epidermis is the first barrier of an animal that protects
against water loss and the biological and physical stress
caused by the external environment. The epidermis consists
of a keratinised stratified epithelium (interfollicular epidermis,
IFE) that can also include appendages such as hair follicles
(HFs) and sebaceous glands (SG). Together, these structures
help to protect and thermoregulate the organism. The
epidermis originates from a single layer of ectodermal cells
during embryonic development. This single layer of ectoder-
mal precursor cells undergoes a stratification process that
forms the different layers of the differentiated cells (basal,
spinous, granular and cornified layers), which all together
function as a barrier. The basal layer consists of highly
proliferative cells that express high levels of basal integrins,
keratin 5 (K5) and keratin 14 (K14). The mature epidermis
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undergoes homeostatic regulation as basal cells periodically
terminally differentiate and migrate outward in a columnar
fashion (Figure 1a). Homeostasis and the repair capability of
adult skin are maintained by the epidermal stem cell (SC)
compartments in the IFE, HFs and SGs.6 SCs in the HFs are
maintained in a specialised microenvironment defined as the
bulge (Figure 1b). Bulge SCs are characterised by their slow
cycle and the expression of specific markers, such as K15,
K19 and Lgr5.7,8 During the hair cycle process, HFs alternate
phases of growth and degeneration. The SCs from the bulge
mediate the regeneration phase of the HF cycle by producing
transient amplifying cells (TA) in the HF matrix.7 In response
to injury, bulge SCs rapidly migrate up to repair the damaged
epidermis, and this migration appears to be tightly regulated
because it stops once the wound is healed. This is a unique
case in which bulge SCs adopt an IFE differentiation
programme.9 Under normal conditions, these cells do not
contribute to the maintenance of the IFE, which suggests that
a separate SC pool in the IFE exists.10 A small unit of SCs in
the basal layer of the IFE provides the precursors that replace
the terminal differentiated keratinocytes.11 These SCs
undergo an asymmetric division that gives rise to a new SC
and a committed cell, which undergoes repeated rounds of
symmetric division to supply the basal compartment with
highly proliferative keratinocytes. In addition to the bulge and
IFE SC populations, there is also evidence of epidermal
progenitors in SGs. A population of resident SCs in the upper
HF that express a high level of MTS24 have been shown to
maintain SG homeostasis (Figure 1b).12,13 Two studies from
the laboratories of Fuchs andMillar have identified the specific
miRs that are expressed in the developing skin and hair
follicles of the mouse.2,4 Although they used different
approaches – Fuchs analysed the E17.5 mouse embryo IFE
and HF and Millard analysed fully thick skin of P1 mice – there
is a significant overlap in the miR profiles reported. The most
significant findings indicate that miR-16, miR-20, miR-21,
miR-24 and miR-125b are the most highly expressed miRs in
the IFE and HF. miR-203, the miR-200 family (i.e., miR-200a,
miR-200b, miR-200c, miR-141 and miR-149) and the miR-19
family (i.e., miR-19b, miR-17–5p and miR-93) appear to be
preferentially expressed in the epidermis, whereas the miR-
199 family (miR-199a and miR-199b) is only expressed in hair
follicles.2,4
p63, a member of the p53 family of genes, is thought to be a
master regulator in ectodermal/epithelial development. The
presence of an additional internal promoter in the gene allows
for the expression of a N-truncated isoform, DNp63, in
addition to the full-length isoform TAp63. TAp63 is the isoform
mainly sharing common function with the better-characterized
member of the family, p53. TAp63 indeed is able to induce cell
cycle arrest and cell death following DNA damage, similarly to
p53 and TAp73.14 TAp63 has been additionally involved in
metastasis suppression, through different mechanisms
including regulation of Sharp-1, Dicer and miRs.15,16 TAp63
can therefore be considered a tumour suppressor protein.17
DNp63 is highly expressed in SCs and the TA cells of the
epidermis (basal layers) and other stratified epithelia, and it is
progressively downregulated during terminal differentia-
tion.18,19 Since the generation of two independent p63 /
mouse models, from the laboratories of Mckeon20 and
Figure 1 (a) Schematic diagram of the mouse skin epithelium. Basal layer keratinocytes (violet) adhere to the underlying basement membrane (basal lamina, grey). Basal
keratinocytes lose their proliferative ability when they detach from the basement membrane and migrate towards the epidermal surface (spinous layer, orange; granular layer,
green; stratum corneum, dark green). An epidermal interfollicular proliferative unit (basal layer) is composed of stem cells and transiently amplifying cells, which divide a few
times and then leave the basal layer to execute their differentiation programme. K5, K14, TG2 and BPAG1 are specific markers for the basal layer. Different intermediate
differentiation steps occur in the spinous and granular layers. Markers for the spinous layer include K10, K1, TG1 and TG5. Markers for the granular layer – Loricrin, Filaggrin
and Involucrin. The cornified layer represents the final phase of terminal differentiation. miR-205 is exclusively and specifically expressed in the basal layer. miR-24, miR-203,
miR-574, miR-720 and mir-34a are pro-differentiation miRs expressed in the epidermal suprabasal compartment. (b) Schematic diagram illustrating the following different
epidermal SC populations found in the skin epidermis: the IFE SCs (shown in violet), the bulge SCs (Bu in orange), the isthmus SCs (Is in green). IFE SCs specifically express
K5 and K14; bulge SCs specifically express K15, K19 and Lgr5; and isthmus SCs specifically express MTS24 and Kgr6. miR-205 is expressed in IFE and bulge SCs, and miR-125b
is only expressed in bulge SC. Panel b is a modified version of a previously published illustration.69 K5, cytokeratin-5; K14, cytokeratin-14; K10, TG2, transglutaminase-2;
cytokeratin-10; K1, cytokeratin-1; TG1, transglutaminase-1; TG5, transglutaminase-5; Fila, Filaggrin; SC, stem cell; HF, hair follicle; IS, isthmus; SG, sebaceous gland
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Bradley,21 the role that p63 has in epidermal development has
become controversial. Although both of the p63 / mouse
models lack an epidermis and epidermal appendages, have
severe limb and craniofacial defects, and die soon after birth,
the precise role that p63 has in ectodermal/epithelial biology
remains unknown. In contrast with the mouse model
generated in the Bradley laboratory, the p63 / mouse
described by Mckeon displays patches of differentiated
keratinocytes that express terminal differentiation markers
(involucrin, loricrin and filaggrin). These patches were inter-
preted to be remnants of a developing epidermis that could not
be maintained during embryogenesis. This finding suggests
that p63 is required for epidermal stem cell maintenance.20 In
contrast, the p63 / mouse model described by Bradley
does not appear to express any of the differentiation markers
in the epidermis or stratified epithelia. Because the epidermis
of this p63 / mouse model exhibits only a faint and patchy
K14 expression pattern and lacks a stratified structure and
because epidermal development appears to cease at
approximately E9.5, p63 was considered to be a determining
factor in epithelial stratification. Another study by Mckeon
using epithelial thymus cells, however, demonstrated that p63
does not has a role in proliferation per se but is required to
maintain the highly proliferative potential of the SCs of the
thymic epithelium. p63 ablation did not affect the incorporation
of 5-bromodeoxyuridine in the overall epithelial thymic
population, but did affect the amount of apoptosis in the
epithelial thymic SC population.22 This study supports the
importance of p63 in epithelial SC and distinguishes p63
contribution to proliferative potential versus its contribution in
maintaining the stem cell niche or forestalling differentiation.
In the debate on interpretation of the failure of p63 /
embryos to develop stratified epithelia, a study by Shalom-
Feuerestein et al.23 showed that p63 / epithelia (either
mouse model) failed to develop beyond ectodermal stage and
remained a monolayer of nonproliferating cells expressing
K8/K18. This suggested the function of p63 as an ectodermal
gatekeeper, promoting epidermal commitment during ES cell
differentiation. This is in line with the demonstration by
Khavari’s group24 that somatic epidermal cells in which p63
has been inactivated become K8-positive ectodermal cells.
Recent findings indicate that a complex network and
reciprocal interactions between miRs and p63 regulate the
fate of epidermal cells. In this review, we discuss the recent
findings in this field and try to provide a unified view of how
the balance between p63 and miRs regulates epidermal
biology.
DNp63 is Essential for Epidermal Morphogenesis
To elucidate the precise role that p63 has in epidermal
biology, selective knockout models for the most highly
expressed p63 isoform in the epithelia, DNp63, have been
generated. The recently generated DNp63-null mouse
described by Flores (hereafter indicated as DNp63D/D),
however, raised further complexity in the dissection of p63
function in epithelia.25 Lack of DNp63 in Flores’ model mainly
phenocopied the gross morphology of the DNp63 mouse
epidermis described by Romano et al.26 (hereafter indicated
as DNp63gfp/gfp), which is partially similar to the phenotypes of
both of the p63 / mouse models that lack all of the p63
isoforms.20,21 The Flores and Romano mouse models clearly
indicate that DNp63 is indispensable for normal epidermal
development and stratification. The DNp63D/Dmice were born
at the proper Mendelian ratios but died within hours after
birth, which is similar to the p63 / mice. DNp63D/D mice
developed a rudimentary stratified epithelium with nests of
basal epidermal cells that appeared in patches in over
20–30% of the embryo (over 5–10% of the embryo). DNp63D/D
embryos (E18.5) expressed the basal markers K5 and K14 in
a few epidermal patches that were organised in an aberrantly
expanded basal layer. In some areas, the suprabasal layer
makers K10 and Filaggrin were also detected. These findings
suggest that the DNp63D/D epidermis attempts to terminally
differentiate but the process is severely defective. The
expression pattern of the suprabasal markers resembles the
expression patterns observed in the p63 / Mckeon strain in
which some patches of differentiated keratinocytes were
identified.20 Interestingly, in contrast with heterozygous
DNp63þ /gfp mice, which appear to be indistinguishable from
their wild-type littermates, the heterozygous DNp63þ /D mice
described by Flores have a phenotype that is an intermediate
between the wild-type and DNp63D/D phenotypes. A morpho-
logical analysis of the epidermis revealed that the DNp63þ /D
mice have an expanded epidermal basal layer with basaloid
cells above the basal epithelium and multiple cell layers with
uneven expression patterns of K5, K14, K10, K1 and
Filaggrin. The presence of an expanded epidermis suggests
that the epidermal cells were hyperproliferative and may have
the ability to self-renew. The epidermis of DNp63þ /Dmice and
the epidermal patches in the DNp63D/D embryos incorporated
5-bromodeoxyuridine at a higher rate, which indicates that
they have a hyperproliferative phenotype. Furthermore, serial
passages of DNp63þ /þ and DNp63D/D epidermal cells
demonstrated that the DNp63 depleted cells retain their
proliferation potential in late passages, which is a point at
which the wild-type cells have already undergone irreversible
cell cycle arrest. Therefore, the deletion of DNp63 appears to
sustain the proliferation and self-renewal capabilities of these
cells. However, contradictory findings have also been
reported. By using an ex vivo model of regenerating human
epidermis, Khavari lab reported that loss of p63 resulted in
severe tissue hypoplasia and inhibition of stratification and
differentiation of the keratinocytes, indicating the necessity of
p63 for both proliferative and differentiation potential of the
epidermis.24 In agreement with Flores, Roop’s group instead
reported that suprabasal proliferating cells were consistently
observed in the skin of an epidermal-specific inducible
knockdown mouse model for DNp63, once DNp63 silencing
was induced in newborn mouse epidermis after normal
embryonic development. This finding indicates that there is
a delay or a defect in the ability of basal keratinocytes to
withdraw from the cell cycle.27 This finding also suggests that
DNp63 and TAp63 may have contrasting roles in epidermal
proliferation. The selective inactivation of TAp63 is asso-
ciated with defective proliferation and the early senescence
of dermal and epidermal precursors, which results in
premature ageing, skin ulcerations and epidermal cell
senescence.28 A balance between the p63 isoforms may
be required for proper epidermal homeostasis. Indeed,
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although the DNp63 knockout mouse models have pheno-
types that are similar to the full p63 / mouse model, their
phenotypes are not completely identical to the phenotype
observed with total p63 ablation.
DNp63 Depletion Induces Multipotency in Epidermal Cells
A striking phenomenon observed in Flores’ mouse model was
that, owing to their self-renewal capacity, the DNp63D/D
epidermal cells expressed higher levels of markers for
embryonic stem cells and fibroblasts induced to become
pluripotent. The ablation of DNp63 induced epidermal cells to
become multipotent.25 These multipotent cells demonstrated
features and expression profiles that resembled the those
observed in induced pluripotent stem cells obtained from
fibroblasts using Yamanaka factors (miPSYam).29 Epidermal
DNp63D/D cells expressed Nanog, Oct4, Sox2 and SSEA-1
(Figure 2). All of the epidermal DNp63D/D cells, however, did not
express the pluripotency markers at the same level. This high
variation in expression levels suggests that a specific in vitro
clone selection processmayhaveoccurred and raises additional
questions.What additional factors are these cells acquiring to be
selected as highly pluripotent cells? Are these selected clones
derived from epidermal stem cells or are they stochastically
selected from the entire epidermal population?
miR biogenesis has been shown to be critical for maintain-
ing pluripotency.30 miRs help to silence the ability of ES cells
to self-renew, and this process normally occurs with the
induction of differentiation.3,4,31 Experiments using knockout
ES cells have shown that DGCR8, the RNA-binding protein
that assists Drosha in miR processing, is essential for
downregulating the expression of pluripotency markers
and promoting ES cell colony differentiation.31 DNp63
transcriptionally regulates DGCR8. DNp63D/D epidermal cells
express a lower level of DGCR8 compared with wt cells.
Furthermore, it has also been shown that DNp63 can directly
bind to and transactivate a p53-like responsive element in
intron 1 of the DGCR8 gene. A global miR expression profile
demonstrated that the expression levels of miRs previously
described as crucial for cell reprogramming, such as miR-
369,30 are downregulated in DNp63D/D epidermal cells. The
overall miR signature revealed that the DNp63D/D epidermal
cell line partially resembled the miPSYam and mES cell
expression profiles, and the ectopic expression of DGCR8 in
these cells produced a signature that was very similar to the
signature observed in wt keratinocytes. Furthermore, the
expression profile of DNp63D/D did not reveal a global
downregulation in miR biogenesis, but specific changes in
the expression pattern that included the downregulation of
some miRs and the upregulation of others.25 This finding
suggests that in addition to reducing DGCR8 expression and
the consequential downregulation in miR biogenesis, addi-
tional mechanismsmay also be responsible for the DNp63D/D
epidermal cell phenotype.
It has also been shown that DNp63D/D epidermal cells have
the ability to differentiate into multiple cell types in vitro and
Figure 2 DNp63 downregulation promotes epidermal cells to become multipotent. Epithelial programming is characterised by the expression of specific markers, such as
K5, K14 and filaggrin. The basal keratinocyte epithelial programme is maintained by an active DNp63/DGCR8 axis, which ensures a correct miR expression profile. Loss of
DNp63 results in DGCR8 downregulation, which impairs normal miR maturation. These events result in the cells becoming multipotent and expressing the multipotent stem
cell marker Sox2, Nanog, Oct4 and SSEA1. Specific environmental conditions allow these cells to re-differentiate into different tissue types, such as mesoderm, endoderm or
ectoderm. Each re-differentiation programme is characterised by the expression of specific markers (Brachyury, AFP and Nestin)
MicroRNAs and p63
E Candi et al
15
Cell Death and Differentiation
in vivo. Culturing these cells in specific epidermal or
neuroectodermal medium promotes terminal differentiation,
which results in the expression of specific differentiation
markers for two different cell lineages. An additional require-
ment for terminal differentiation, however, was the ectopic
expression of DGCR8 in DNp63D/D cells. This requirement
was confirmed in vivo in a teratoma model and by injecting
DNp63D/D cells in mouse blastocysts. DNp63D/D epidermal
cells that expressed DGCR8 were able to differentiate into
skin, muscle, liver and brain cells in vivo (Figure 2). E18.5
chimera embryos generated from a GFP-expressing
DNp63D/D epidermal cell line showed that the DNp63D/D cells
contributed to 70–80% of the mouse embryo. The GFP-
positive cells were also found to express keratin 5 in the skin,
villin in the intestinal tract, AFP in the liver and nestin in the
brain.25 These chimera embryos, however, demonstrated
severe abnormalities in the expression patterns of epithelia
markers, and they died shortly after birth because of skin
defects. Contrasting findings on the involvement of p63 in
stem cell reprogramming have been reported by the other
groups. DNp63 appeared to be essential for the reprogram-
ming of MEFs by OSK (Oct4, Sox2 and Klf4). Moll32 reported
that loss of p63 affects reprogramming through several
mechanisms, such as reducing the expression of
mesenchymal–epithelial transition and pluripotency genes,
hypoproliferation and loss of the most reprogrammable cell
populations. The depletion of p63, however, did not affect the
maintenance of the iPSCs derived from MEFs, which
indicates that it is only important in the reprogramming
process. Another study suggests that p63 loss in mouse ES
cells still allows the generation of K8/K18 epithelial cells, but
impairs the full commitment to K5/K14 positive epidermal
cells.33 Clearly, the work by Flores adds another level of
complexity to the functional role that p63 has in epidermal
biology and stem cell maintenance. Although many questions
remain in this field, this study alludes to an additional strategy
to achieve the fascinating possibility of extracting epidermal
cells from patient skin biopsies and reprogramming the
keratinocytes into multipotent stem cells for various thera-
peutic strategies.
miRs-p63 Loops in Epidermal Differentiation
Disruption of miR processing in the skin, by the conditional
deletion of Dicer, results in abnormalities in epidermal
stratification and suggests that miRs have important roles in
keratinocyte differentiation. Several recent studies further
highlight the importance of miR-p63 loops in regulating
epidermal stratification (Table 1). miR-203 was the first miR
implicated in driving epidermal differentiation. miR-203 is
rapidly upregulated when primary keratinocytes exit the cell
cycle and are induced to differentiate.34,35 In the mouse skin,
miR-203 expression is only detectable in the suprabasal
layers and the differentiated sheets of mature hair follicles.35
MiR-203 targets the 30UTR of p63 and directly represses
DNp63 expression in the suprabasal layers. The ectopic
expression of miR-203 in the basal layer of mouse skin
resulted in perinatal lethality, which was associated with a lack
of epidermal basal progenitors and the detection of sporadic
DNp63-expressing cells.35 These findings strongly implicate
that p63 is an essential regulator of stem cell maintenance in
stratified epithelial tissues. It has been shown that miR-203 is
transcriptionally activated in the differentiating daughter cells
resulting from the asymmetric cell division of interfollicular
progenitor cells. miR-203 rapidly promotes exiting the cell
cycle within 6 h and abolishes the self-renewal ability of the
progenitor cells. However, only the co-suppression of the
miR-203 individual targets (including p63, Skp2 and Msi2) is
sufficient for promoting exiting the cell cycle and inhibiting
long-term proliferation.36 This finding demonstrates that not
all of the effects of miR-203 are the result of p63-dependent
repression. miR-203 defines a molecular boundary between
proliferative basal progenitors and terminally differentiating
suprabasal cells, which ensures the proper identification of
neighbouring layers. A novel autoregulatory feedback loop
involving iASPP/p63/miRs has been implicated in maintaining
homeostasis of the stratified epithelia.37 iASPP belongs to the
family of apoptosis-stimulating proteins of p53 (ASPP), which
regulates p53-family mediated apoptosis. iASPP is mostly
expressed in epithelial tissues and preferentially binds to p63.
DNp63 and iASPP are coexpressed in basal epidermal cells at
E15.5 and reciprocally regulate each other. DNp63 transcrip-
tionally controls the expression of iASPP while iASPP
represses the expression of two miRs, miR-574 and miR-
720, that translationally repress DNp63 expression (Figure 3).
iASPP / keratinocytes are not as proliferative and prema-
turely differentiate, and these phenotypes are partially
rescued by inducing the expression of miR-574 and miR-
720. However, iASPP depletion does not completely photo-
copy p63 depletion. The downregulated expression pattern of
adhesion molecules observed in p63-depleted cells (reduced
expression of integrin b1, b2 and a3) is not precisely
reproduced in iASPP-depleted cells (reduced expression of
integrin b1 and increased expression of integrin a3). Another
difference between the two phenotypes is the premature
differentiation of iASPP / keratinocytes, which does not
occur withDNp6325,26 or full p63 depletion.24 OthermiRs have
also been implicated in regulating the proliferation of
epidermal progenitor cells and maintaining the stem cell
population (Figure 4). Recently, miR-24 has been identified as
a critical regulator of keratinocyte differentiation that functions
Table 1 MiRs involved in epidermal homeostasis
miR Function Target/s Ref
miR-203 Keratinocyte proliferation/
differentiation
p63
Skp2
Msi2
34–36
miR-574
miR-720
Keratinocyte proliferation/
differentiation
p63 37
miR-24 Keratinocyte differentiation/actin
cytoskeleton
PAK4
Tsk5
ArhGAP19
Tcf3
38,39
miR-205 Epidermal Stem cells 41
miR-180
miR-130a
miR-181a
miR-181b
miR-138
Keratinocyte senescence p63
SIRT1
46,50
miR-191 Keratinocyte senescence Satb1 49
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by regulating the rearrangement of the actin cytoskeleton.
Similar to miR-203, miR-24 is expressed in differentiated
compartments of the epidermis. The ectopic expression of
miR-24 in the basal layer of the mouse skin results in the
premature expression of differentiation markers, and an early
exit from the cell cycle. A few days after birth, miR-24
transgenic mice (K14::miR-24 Tg) are significantly
smaller compared with their wt littermates and die, most
likely from malnutrition. Although the general architecture
appeared normal, their skin was thinner and several
basaloid cells were positive for the spinous layer marker
K10, which is indicative of accelerated differentiation. It has
been shown that miR-24 targets actin cytoskeleton mod-
ulators, including PAK4, Tsk5 and ArhGAP19, that promote
a switch from a basal to a suprabasal actin cytoskeleton
architecture, which promotes keratinocyte differentiation
(Figure 5).38 Furthermore, the miR-24 transgenic mice HF
bulge has a severely depleted SC compartment.39 The
balance between stem cell renewal and differentiation is
also tightly regulated by extrinsic signals from the extra-
cellular matrix and the arrangement of the actin cytoskele-
ton. SC differentiation required the concomitant regulation
of the serum response factor activity and a dense cortical
F-actin cytoskeleton. Thus, actin cytoskeleton-mediated
shape-induced differentiation has been shown to be a
determining factor in epidermal cell fate.40
In addition to these pro-differentiation miRs, miR-205 has
been shown to have a pivotal role in the expansion of the SC
population. The genetic deletion of miR-205 results in
neonatal lethality and severely compromised epidermal and
hair follicle growth. miR-205 / epidermal SCs prematurely
exit the cell cycle and undergo transition towards
quiescence.41 An expression profile analysis of miR-205 /
HF–SCs revealed a downregulation in the PI(3)K/Akt pathway
Figure 3 iASPP regulates the proliferation/differentiation switch in keratinocytes by regulating a miRs/p63 axis. Under normal conditions, p63 regulates iASPP expression,
which represses the expression of miR-574-3p and miR-720. miR-574-3p and miR-720 repress p63 expression, providing a feedback loop, which maintains the proliferation/
differentiation balance. iASPP knockout keratinocytes demonstrate defective differentiation programmes that are associated with an upregulation in the expression of these
miRs and the inhibition of p6312
Figure 4 Senescence and differentiation of keratinocytes are regulated by a
complex DNp63/miRs network. DNp63 is highly expressed in proliferating
keratinocytes (K5 and K14 positive). Upon differentiation or the initiation of the
senescence programme, DNp63 expression is progressively downregulated.
During differentiation the miR-574, miR-720, miR-34 and miR-203 expression levels
are progressively upregulated. In this context, miR-574, miR-720 and miR-203
directly target DNp63, repressing its expression, and DNp63 maintains the
proliferative ability of the cell by repressing the expression of miR-574, miR-720 and
mir-34a. During senescence, the miR-130, miR-181 and miR-138 expression levels
are upregulated. miR-130/DNp63 reciprocally repress the expression of each other.
DNp63 also represses the expression of the pro-senescence miRs miR-181 and
miR-138. The fine balance of this complex network regulates the keratinocyte fate
MicroRNAs and p63
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activity, which stresses the importance of this pathway in
sustaining the SC cell cycle. Therefore, miR-205 has a role in
the expansion of the SC population, and its downregulation
results in the transition to quiescence and towards
differentiation.
miR-p63 Loops in Epidermal Senescence
Epidermal tissue needs to be continuously renewed through-
out life, and keratinocyte stem cells contribute to normal tissue
homeostasis and regeneration in response to injury or
stress.42 There is a decline in the regenerative potential of
the tissue that occurs with age that may be due to the result of
the intrinsic ageing of the stem cells overtime. The accumula-
tion of senescent cells over timemost likely reduces the tissue
regenerative capability and contributes to the physiological
ageing of the tissue.43,44 In vitro, senescence can result from
multiple types of cellular stress, such as overproduction of
ROS, oncogene activation, telomere shortening and by simply
terminating the replicative potential, which is known as
replicative senescence. In tissues with a high turnover rate,
such as the epidermis, replicative senescence has a crucial
role in regulating time-dependent changes, and several
studies have demonstrated that miRs are intimately involved
in these processes. p63 has a crucial role in counteracting
ageing/senescence in vitro and in vivo. Furthermore, p63 and
p63-isoform specific depletions induce premature ageing in
different mice models.28,45 An interesting correlation between
the p63 expression levels and cellular senescence
and/or ageing has also been demonstrated in human
keratinocytes.46,47 Most notably, a genomic-wide miR profil-
ing study has shown that several miRs (miR-138, miR-181a,
miR-181b, miR-191 and miR130b) are significantly upregu-
lated in senescence human keratinocytes compared with
proliferating keratinocytes. Of these identified miRs, miR-
130a, miR-181a, miR-181b and miR-138 target the 30UTRs of
p63 and SIRT1, which are themolecules that are expressed in
the basal layer and are strongly associated with keratinocyte
proliferation and the maintenance of epidermal progenitor
cells. The importance of miR-181a, miR181, miR-138 and
miR-130a and their targets, p63 and SIRT1, has also been
studied in skin ageing in vivo. A study evaluating groups of
healthy young (o10 years old) and older (460 years old)
human subjects showed that the senescence-associated
miRs were significantly upregulated in aged skin, which
paralleled a significant downregulation in their targets p63 and
SIRT1.46,47 The importance of p63 in regulating the epidermal
differentiation/proliferation programme is eloquently illu-
strated in two recent papers that demonstrate that p63
transcriptionally controls DNA- and chromatin-remodelling
factors (Brg1 and Satb148,49). In mouse epidermal progenitor
cells, p63 directly regulates the transcription of the ATP-
dependent chromatin remodeller Brg1 and the genome
organiser Satb1. Both factors bind to distinct domains within
the epidermal differentiation complex, which is required for
epidermal morphogenesis. Interestingly, the senescence-
associated miR-191 targets the Satb1 30UTR and links miRs
to the remodelling of higher-order chromatin structures.48,50
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Figure 5 miR-24 promotes keratinocyte differentiation by repressing pro-proliferation factors and actin cytoskeleton modulators. In wt mice, miR-24 expression is confined
to the suprabasal layers, where it represses the expression of Myc and E2F2, which determine when the cell exits the cell cycle, and PAK4, ArhGAP19 and Tks5, which
promote actin cytoskeleton rearrangement. miR-24-dependent cell cycle exit and actin cytoskeleton rearrangement promote the proliferation/differentiation switch. In Tg
K5::miR-24 mice, the ectopic expression of miR-24 in basal keratinocytes promotes early cell cycle exit and actin cytoskeleton rearrangement, which accelerates
differentiation. The premature differentiation is confirmed by the expression of suprabasal markers in the basal layer. Tg K5::miR-24 mice demonstrate a severe body weight
loss and have a thinner epidermis. Although the normal epidermal architecture is maintained, the epidermal compartments have a reduced number of cell layers38
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miRs and p63 in Cancer
DNp63 lacking the transactivation domain TA can function as
a dominant negative protein of TAp63 and TAp73 and inhibit
their function in cell cycle arrest and apoptosis.51 Mutations in
p63 are extremely rare in human cancers. Most head and
neck squamous cell carcinomas, and other squamous cell
epithelial malignancies and non-small-cell lung cancer not
only retain p63 expression, but are also often overexpressed
and occasionally amplified.52–54 An in vivo mouse model
showed that established squamous cell carcinomas (SCCs)
are dependent on p63; the acute genetic ablation of p63
rapidly induced apoptosis and tumour regression.55 The
p63-targeting miR miR-203 has an important role as a tumour
suppressor in different cancer types, including chronic
myelogenous leukaemia. In chronic myelogenous leukaemia,
miR-203 represses the expression of the oncoprotein c-Abl,
which is often involved in the genomic translocation of the
Philadelphia chromosome (BCR-ABL).56 miR-203 also acts
as a metastasis suppressor in epithelial cancers. miR-203 is
sufficient to induce a mesenchymal to epithelial transition with
inhibition of cell proliferation, migration and invasiveness in
brain and bone metastatic prostate cell lines.57 Another miR
that is also involved in metastasis is miR-205. In prostate
cancer, miR-205 has been shown to affect p63 metastasis
suppressor function through direct transcriptional regulation.
miR-205 is essential for the inhibitory effects of p63 on
markers of epithelial–mesenchymal transition (EMT), such as
ZEB1 and vimentin. p53 mutants inhibit the expression of p63
and miR-205, which promotes cell migration and metastasis.
Clinical data have shown that metastasising human prostate
cancer cells demonstrate a loss of one or both components of
the p63/miR-205 axis (Figure 6).58 p63 has also been shown
to regulate the expression of miR-155, thus promoting tumour
suppression and metastasis suppression in epithelial cancer
cell lines.59 miR-34a is also involved in a wide interplay with
the p53 family. miR-34a is a well-established target and
mediator of p53 function with a similar context-dependent
involvement in growth arrest, senescence, and apoptosis.60
p63 transcriptionally represses the expression of miR-34a,
which reduces the proliferation of primary keratinocytes. The
deletion of p63 in human keratinocytes increased themiR-34a
andmiR-34c expression levels and inhibited the expression of
cell cycle regulators (cyclin D1 and Cdk4) with a concomitant
G1-phase arrest.61 miR-34 also promotes the differentiation
of different cell types, including neurons62,63 and keratino-
cytes.64 Consistent with this function, miR-34a is frequently
repressed in SCCs. Reversing genomic DNA methylation
restores miR-34a expression and promotes the differentiation
of malignant keratinocytes.64 Among the oncogenic miRs
miR-21 is one of the most commonly overexpressed miRs in
carcinomas, including prostate, breast, pancreas, colon, head
and neck.65 Knockout of miR-21 in mice revealed that this miR
has a direct role in promoting epidermal tumourigenesis.
miR-21-null mice demonstrated a significant reduction in skin
papilloma formation in chemical-induced carcinogenesis
experiments. The upregulation of Spry1, PTEN and Pdcd4
was observed in miR-21 / keratinocytes, which is asso-
ciated with reduced activation of the major downstream
effectors of RAS signalling, which is fundamental for skin
carcinogenesis initiation.66 miR-21 also targets Grhl3, a
transcription factor that functions as a tumour suppressor in
epidermal SCC. miR-21 activates a proto-oncogenic network
that represses Grhl3 expression and results in a loss of PTEN
expression, which is a direct GRHL3 target. miR-21 activation
results in an aggressive SCC induced by PTEN repression
and the consequent activation of PI3K/AKT/mTOR signal-
ling.67 A recent study has illustrated the importance of
K15-positive epidermal SCs (bulge cells) and miRs in the
tumourigenesis and metastasisation of epidermal cancer.
A mouse model of SCC, which was generated by targeting
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EMT 
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Figure 6 p63/miR-205 axis inhibits EMT, migration and metastasis. (i) When
the p63/miR-205 axis is functional, p63 transcriptionally promotes the expression of
miR-205, which negatively regulates the expression levels of the pro-EMT factors
Zeb1 and Sip1. These events inhibit EMT, migration and metastasis of cancer cells.
(ii) When mutant p53 (mp53) is expressed, it negatively regulates p63 activity.
This expression impairs the p63/miR-205 axis, which results in Zeb1 and Sip1
accumulation and increased EMT, migration and metastasis
Table 2 MiRs involved in epidermal cancer
miR Expression Function Target/s Ref
miR-21 Up Cell cycle
progression
PTEN, PCDC4,
GRHL3
66,67
miR-34a Down Cell cycle
progression
Cyc D1, Cdk4, Sirt6 61,64
miR-203 Down Cell cycle
progression
p63, cJun 70
miR-9 Up Metastasis a-Catenin 68
Let-7 Down Cell cycle
progression
KRas 71
miR-124 Down Cell cycle
progression
ERK2 72
miR-214 Down Cell cycle
progression
ERK1 72
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two frequent genetic mutations found in human SCCs,
oncogene KrasG12D activation and Smad4 deletion in mouse
K15–expressing SCs, revealed a fundamental function of
miR-9 in regulating the expansion of metastatic cancer stem
cells. miR-9 is expressed in metastatic human SSCs and
activates the invasive ability of SCC cells repressing a-catenin
expression.68 Regulating the expression of these miRs
(Table 2) in tumour cells should be considered for use in
novel therapeutic strategies in epidermal cancers.
Concluding Remarks
p63 acts as a central hub in epidermal biology. Modulating p63
activity alters the balance between keratinocyte stemness,
differentiation and senescence. Several miRs are crucially
involved in this network and act as either downstream or
upstream regulators of p63 function. Furthermore, the
transcriptional regulation of the miR processor complex
(DGCR8 by DNp63 and Dicer by TAp63) by p63 further
illustrates the importance and complexity of the p63-miR
network. Characterisation of isoform-specific p63 knockout
mice has not definitively solidified our understanding of the
roles of the various p63 isoforms in these biological
processes. The recent generation of DNp63 selective knock-
outs has instead illustrated the complexity of this network. For
example, TAp63 has only a minor role in epidermal develop-
ment, but contributes to the maintenance of adult skin stem
cells and senescence. It appears that both p63 isoforms must
be precisely regulated for epidermal homeostasis. How are
the functions of these two isoforms integrated? Do their
functions partially overlap or counteract each other or do they
function in parallel processes?
The involvement of miRs in these phenomena stresses the
complexity of this process. A single miR can simultaneously
affect dozens of target genes, which can result in a wide
change in the expression profile. The molecular dissection of
these signalling pathways is fundamental for fully elucidating
these processes. This aspect is particularly relevant for
epidermal diseases. Alternative and innovative therapeutic
strategies for skin cancer may be developed by targetingmiR
expression. Answering these and other questions will
provide the future research in this field with important
challenges.
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